Clinical Trial Update: Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation

View source ↗

Summary

This clinical trial update reports the clinical and economic outcomes of oral anticoagulants in patients with non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-Valvular Atrial Fibrillation | Status: COMPLETED